From Safety Signals to Confident Decisions.
The Signal Detection & Safety Governance Playbook provides a practical framework for building and strengthening pharmacovigilance signal management programs. Covering governance structures, surveillance strategies, signal identification, validation, evaluation, benefit-risk assessment, safety committee operations, and risk action implementation, it helps organizations create compliant, inspection-ready processes that support timely, evidence-based safety decisions. The playbook also includes templates, checklists, and implementation guidance to accelerate governance maturity and operational excellence across PV, medical, regulatory, clinical, and quality functions.
Table of Contents
Chapter 1. Signal Detection and Safety Governance Fundamentals
1.1 What Signal Detection and Safety Governance Must Achieve
1.2 Core Definitions: Signal, Risk, Validation, Evaluation, and Action
1.3 Regulatory Expectations and Inspection Readiness
1.4 The End-to-End Signal Management Lifecycle
1.5 Maturity Diagnostic: Is the Current Model Fit for Purpose?
Chapter 2. Governance Model, Roles, and Decision Rights
2.1 The Safety Governance Operating Model
2.2 Roles Across PV, Medical, Regulatory, Clinical, and Quality
2.3 Decision Rights, Escalation Paths, and RACI Design
2.4 Committee Architecture and Safety Decision Forums
2.5 Governance Charter Template and RACI Checklist
Chapter 3. Data Sources, Surveillance Strategy, and Signal Identification
3.1 Building the Signal Detection Strategy
3.2 Core Sources: ICSRs, Literature, Clinical Data, and Aggregate Reports
3.3 Additional Sources: Real-World Data, Registries, and Digital Channels
3.4 Quantitative and Qualitative Detection Methods
3.5 Surveillance Plan Template and Identification Checklist
Chapter 4. Signal Triage, Validation, and Prioritization
4.1 Intake and Triage of Potential Signals
4.2 Validation Criteria and Evidence Thresholds
4.3 Medical Review, Case Series Analysis, and Causality Assessment
4.4 Prioritization by Patient Risk, Product Criticality, and Urgency
4.5 Signal Validation Memo Template
Chapter 5. Signal Evaluation, Benefit-Risk Assessment, and Documentation
5.1 Designing the Signal Evaluation Workplan
5.2 Clinical, Epidemiologic, Nonclinical, and Literature Assessment
5.3 Benefit-Risk Framing and Risk Characterization
5.4 Signal Closure, Confirmation, or Risk Action Decision
5.5 Signal Evaluation Report Template
Chapter 6. Safety Committee Cadence and Meeting Discipline
6.1 Designing the Committee Calendar and Cadence
6.2 Agenda Design, Pre-Reads, and Decision Packs
6.3 Meeting Facilitation and Challenge Process
6.4 Minutes, Action Tracking, and Governance Evidence
6.5 Committee Effectiveness Checklist
Chapter 7. Risk Actions, Label Changes, and Implementation Tracking
7.1 Translating Signal Outcomes Into Risk Actions
7.2 Label-Change Decision Process and Regulatory Alignment
7.3 Risk Minimization, Communications, and Safety Updates
7.4 Implementation Tracking Across Markets and Functions
7.5 Label-Change Workflow and Action Tracker Template
Chapter 8. Implementation Roadmap and External Support Options
8.1 Building the Signal Governance Improvement Roadmap
8.2 Internal Capabilities, Resourcing, and Change Management
8.3 Support From Large Consulting Firms
8.4 Specialist PV, Regulatory, Medical, and Safety Advisors
8.5 Independent Management Consultants Through Umbrex